Smith & Nephew receives FDA 510(k) clearance for stemless option of TSA system
Click Here to Manage Email Alerts
Key takeaways:
- Smith & Nephew received FDA 510(k) clearance of a stemless option for its Aetos shoulder system.
- The solution is cleared for anatomic total shoulder arthroplasty procedures.
Smith & Nephew announced it received FDA 510(k) clearance of a stemless option for its Aetos shoulder system for anatomic total shoulder arthroplasty, according to a company press release.
The stemless addition to the Aetos TSA system is now approved for use in U.S. and Canada, according to the release.
“Aetos stemless represents a significant advancement in shoulder arthroplasty, underscoring our commitment to superior patient outcomes and driving progress in the field of orthopedic surgery. We are excited to continue unveiling future technologies that will reshape the treatment of shoulder conditions,” Craig Gaffin, president of global orthopedics at Smith & Nephew, said in the release. “With Aetos stemless, we’re now able to further personalize surgery, providing options that help surgeons give patients the best chance for recovery and a return to living their life unlimited.”
Read more about
Click Here to Manage Email Alerts